p97

p97 inhibitors act on valosin-containing protein (VCP), which extracts ubiquitinated proteins from protein complexes. p97 belongs to the ATPases associated with diverse cellular activities (AAA) family and forms a hexamer with two ATPase domains, D1 and D2, per subunit. This segregase activity supports endoplasmic reticulum-associated degradation, proteasomal turnover and autophagy. DBeQ, reported in 2011, is a reversible inhibitor competitive with adenosine triphosphate (ATP) that impairs both ubiquitin-dependent and autophagic protein clearance. NMS-873 and NMS-859, described together in 2013, are allosteric and covalent p97 inhibitors that induce cancer cell death. CB5083 targets the D2 domain and disrupts protein homeostasis in tumor cell models. ML240 and CB-5339 are further ATP-competitive inhibitors, whereas VCP Activator 1 increases p97 activity.

1 Item

  • KUS121
    Cat. No.
    A56813

    KUS121

    KUS121 is a valosin-containing protein (VCP, p97) modulator that exhibits significant neuroprotective properties. It effectively reduces ischemic retinal cell death by inhibiting endoplasmic reticulum stress. This compound has potential applications in studying neurodegenerative diseases and may offer insights into therapeutic strategies for retinal injuries.

    1 mg
    $50.00
    5 mg
    $150.00
    All 6 sizes

1 Item

Added to your cart

View Cart Checkout

    Loading...